Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Elevance Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Elevance Health's operating cash flow for the twelve months ending Sep 30, 2026 was $7.60B, up 54.6% year over year. For fiscal 2025 it was $4.29B, down 26.1% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is $10.69B in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.29B | -26.1% |
| FY2024 | Dec 31, 2024 | $5.81B | -27.9% |
| FY2023 | Dec 31, 2023 | $8.06B | -4.0% |
| FY2022 | Dec 31, 2022 | $8.40B | +0.4% |
| FY2021 | Dec 31, 2021 | $8.36B | -21.7% |
| FY2020 | Dec 31, 2020 | $10.69B | +76.3% |
| FY2019 | Dec 31, 2019 | $6.06B | +58.4% |
| FY2018 | Dec 31, 2018 | $3.83B | -8.6% |
| FY2017 | Dec 31, 2017 | $4.19B | +28.0% |
| FY2016 | Dec 31, 2016 | $3.27B | -22.4% |
| FY2015 | Dec 31, 2015 | $4.21B | +25.0% |
| FY2014 | Dec 31, 2014 | $3.37B | +10.4% |
| FY2013 | Dec 31, 2013 | $3.05B | +11.2% |
| FY2012 | Dec 31, 2012 | $2.74B | -18.7% |
| FY2011 | Dec 31, 2011 | $3.37B | +138.2% |
| FY2010 | Dec 31, 2010 | $1.42B | -53.4% |
| FY2009 | Dec 31, 2009 | $3.04B | +19.9% |
| FY2008 | Dec 31, 2008 | $2.54B | -41.6% |
| FY2007 | Dec 31, 2007 | $4.34B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.27B | +11.6% |
| Q2 FY2026 | Jun 30, 2026 | $1.91B | -6.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.33B | +326.0% |
| Q4 FY2025 | Dec 31, 2025 | $84.00M | -88.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.14B | -57.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.05B | +359.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.02B | -48.6% |
| Q4 FY2024 | Dec 31, 2024 | $706.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $2.68B | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | $447.00M | -77.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.98B | -69.4% |
| Q4 FY2023 | Dec 31, 2023 | -$2.97B | – |
| Q3 FY2023 | Sep 30, 2023 | $2.61B | -46.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.95B | -20.5% |
| Q1 FY2023 | Mar 31, 2023 | $6.47B | +154.6% |
| Q4 FY2022 | Dec 31, 2022 | -$1.52B | -190.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.92B | +96.6% |
| Q2 FY2022 | Jun 30, 2022 | $2.45B | +45.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.54B | +1.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.67B | -56.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.50B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.68B | -69.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.51B | -0.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.81B | +187.3% |
| Q3 FY2020 | Sep 30, 2020 | -$1.15B | -169.0% |
| Q2 FY2020 | Jun 30, 2020 | $5.51B | +283.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.52B | +54.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.33B | +186.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.67B | +174.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.44B | +165.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.63B | -26.4% |
| Q4 FY2018 | Dec 31, 2018 | $463.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $607.00M | -74.8% |
| Q2 FY2018 | Jun 30, 2018 | $542.00M | +37.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.22B | -17.6% |
| Q4 FY2017 | Dec 31, 2017 | -$1.30B | -570.4% |
| Q3 FY2017 | Sep 30, 2017 | $2.40B | – |
| Q2 FY2017 | Jun 30, 2017 | $393.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.69B | – |
| Q4 FY2016 | Dec 31, 2016 | $276.60M | – |
See a number that looks wrong?